Antipsychotic drug prescribing in the elderly is cause for concern

International Clinical Psychopharmacology

Volumn 19, Issue 6, 2004, Pages 347-350

  Percudani, Mauro ^a,c   Barbui, Corrado ^b   Fortino, Ida ^a   Petrovich, Lorenzo ^a  

^a Health Care Directorate   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Regione Lombardia   (Italy)

Author keywords

Antipsychotics; Elderly; Epidemiology; Psychosis

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; THIORIDAZINE;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CEREBROVASCULAR DISEASE; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RISK;

AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DATA COLLECTION; DRUG UTILIZATION; FEMALE; HUMANS; ITALY; MALE; PRESCRIPTIONS, DRUG; PSYCHOTIC DISORDERS; RISPERIDONE; THIORIDAZINE;

EID: 8644257714     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200411000-00006     Document Type: Article

References (15)

1. Barbui C, Campomori A, Mezzalira L, Lopatriello S, Cas, RD, Garratinni S (2001). Psychotropic drug use in Italy 1984-1999: impact of regulatory changes. Int Clin Psychopharmacol 16:227-233.
2. Barbui C, Ciuna A, Nose M, Patten SB, Stegagno M, Burti L, Amaddeo F, Tansella M (2004). Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice. Acta Psychiatr Scand 109:275-278.
3. EMEA (2004). European Agency for the Evaluation of Medicinal Products. Public statement on the safety of olanzapine. EMEA/CPMP/856/04/Final.
4. Fleischhacker WW and the European Group for Research in Schizophrenia (2003). Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use. Psychopharmacology 169: 207-210.
5. Jones G (2003). Prescribing and taking medicines. Concordance is a fine theory but it is mostly not being practised. BMJ 327:819.
6. Lacro JR Jeste DV (1997). Geriatric psychosis. Psychiatr Q 68:247-260.
7. Lernfelt B, Samuelsson O, Skoog I, Landahl S (2003). Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 59:637-644.
8. Menkes DB, Knight JC (2002). Cardiotoxicity and prescription of thioridazine in New Zealand. Austral NZ J Psychiatry 36:492-498.
9. Nose M, Barbui C, Tansella M (2003). How often patients with psychosis fail to adhere with treatment programs? A systematic review. Psychol Med 33:1149-1158.
10. Percudani M, Barbui C, Fortino I, Petrovich L (2004). The prevalence of antidepressant and antipsychotic drug prescribing in Lombardy, Italy. J Clin Psychopharmacol, in press.
11. Regions Lombardia (2003). Regional Community Health Plan 2002-2004. Milan: Direzione Generale Sanità.
12. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048-1052.
13. Smith DA, Beier MT (2004). Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypothesis for an underlying mechanism. J Am Med Dir Assoc 5:129-132.
14. Targum SD (2001). Treating psychotic symptoms in elderly patients. J Clin Psychiatry 3:156-163.
15. Wooltorton E (2002). Risperidone: increased rate of cerebrovascular events in dementia trials. CMAJ 26:1269-1270.